Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Acute radiation proctitis: a sequential clinicopathologic study during pelvic radiotherapy.

N Hovdenak1, L F Fajardo, M Hauer-Jensen

  • 1Department of Oncology, University of Bergen, Bergen, Norway.

International Journal of Radiation Oncology, Biology, Physics
|November 10, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of a controlled gluten challenge in a group of patients with suspected non-coeliac gluten sensitivity: A randomized, double-blind placebo-controlled challenge.

Neurogastroenterology and motility·2018
Same author

Citrulline as a Biomarker for Gastrointestinal-Acute Radiation Syndrome: Species Differences and Experimental Condition Effects.

Radiation research·2016
Same author

Latexin sensitizes leukemogenic cells to gamma-irradiation-induced cell-cycle arrest and cell death through Rps3 pathway.

Cell death & disease·2014
Same author

IKKβ regulates endothelial thrombomodulin in a Klf2-dependent manner.

Journal of thrombosis and haemostasis : JTH·2014
Same author

ICRP publication 118: ICRP statement on tissue reactions and early and late effects of radiation in normal tissues and organs--threshold doses for tissue reactions in a radiation protection context.

Annals of the ICRP·2012
Same author

Disc angiogenesis assay.

Methods in molecular medicine·2011

Radiation proctitis shows early endoscopic and histologic changes, peaking at 2 weeks. Clinical symptoms appear later, with some regression by 6 weeks, impacting treatment timing.

Area of Science:

  • Oncology
  • Gastroenterology
  • Radiation Oncology

Background:

  • Rectal toxicity is a common dose-limiting side effect of pelvic radiation therapy.
  • Understanding the temporal progression of radiation proctitis is crucial for patient management.

Purpose of the Study:

  • To prospectively evaluate the sequential development of clinical, endoscopic, and histopathologic rectal toxicity during pelvic radiation therapy.
  • To identify associations between different measures of rectal toxicity.

Main Methods:

  • Prospective study of 33 patients with pelvic carcinomas undergoing radiation therapy.
  • Serial proctoscopies with biopsies at baseline, 2 weeks, and 6 weeks.
  • Assessment of clinical symptoms, endoscopic findings, and histopathologic changes, including macrophage infiltration.

Related Experiment Videos

Main Results:

  • Histopathologic and endoscopic changes were most pronounced at 2 weeks of treatment.
  • Clinical symptoms of rectal toxicity became more apparent towards the end of the treatment course (6 weeks).
  • Histologic findings showed significant changes including epithelial atrophy, cryptitis, and stromal inflammation early in treatment.

Conclusions:

  • Endoscopic and histologic rectal toxicity peak early in radiation therapy (2 weeks) and show some regression by 6 weeks.
  • Clinical symptoms manifest later in the treatment course.
  • These findings suggest potential windows for interventions to mitigate radiation proctitis.